Newsroom

  • Pulmonary Medicine

    Leader in Care

    Throughout the Washington, DC, region, the nation and the world, Children’s National Health System is recognized for our expertise and innovation in pediatric care and as an advocate for all children.

    Read more
  • Research

    Leader in research

    Our desire to provide the most compassionate clinical care is complemented by our dedication to improving treatments and the quality of life for patients and their families.

    Read more
  • Leukemia Lymphoma Program

    Expert on your side

    Several specially trained people dedicated to children’s medicine care for your child, working together to give your family the best possible treatment.

    Meet a nurse

Latest News

New Study Identifies Which Physical Features Are Best Indicators of Down Syndrome in Diverse Populations

The study, led by the National Human Genome Research Institute (NHGRI), part of the National Institutes of Health, used an objective digital facial analysis technology developed by the Sheikh Zayed Institute for Pediatric Surgical Innovation at Children’s National Health System to identify the most relevant facial features characteristic in Down syndrome in diverse populations from 12 countries. This NHGRI study is the first to compare and contrast Down syndrome across diverse populations.

Home-Based Working Memory Training Reduces Neurocognitive Effects of SCD

Home-based, computerized working memory (WM) training reduces the neurocognitive effects of sickle cell disease among school-aged youths, helping them achieve demonstrated improvements in verbal and visual WM – even if kids complete as few as 10 sessions, according to a research study led by Children’s National Health System.

Children's National Health System to Collaborate with the Regeneron Genetics Center in a Large-Scale Whole Exome Sequencing Research Study of Undiagnosed Diseases

Children's announces the launch of a major three-year research study of undiagnosed diseases in partnership with the Regeneron Genetics Center (RGC, a subsidiary of Regeneron Pharmaceuticals, Inc.). The RGC will conduct whole exome sequencing, which looks at all the protein-coding DNA in a genome, for patients in the study.